NovaBridge Biosciences American Depositary Shares
NBP
44 hedge funds and large institutions have $23.5M invested in NovaBridge Biosciences American Depositary Shares in 2023 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 15 reducing their positions, and 13 closing their positions.
16% more capital invested
Capital invested by funds: $20.1M → $23.5M (+$3.32M)
3.52% less ownership
Funds ownership: 18.46% → 14.94% (-3.5%)
6% less funds holding
Funds holding: 47 → 44 (-3)
15% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 13
33% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 15
83% less call options, than puts
Call options by funds: $1K | Put options by funds: $6K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$512K |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
+$464K |
| 3 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$400K |
| 4 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$243K |
| 5 |
Two Sigma Advisers
New York
|
+$220K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
-$1.12M |
| 2 |
BlackRock
New York
|
-$931K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$812K |
| 4 |
Morgan Stanley
New York
|
-$705K |
| 5 |
JP Morgan Chase
New York
|
-$631K |
NBP Hedge Fund Activity: Q4 2023 in Review
44 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q4 2023, worth a combined $23.5M — up 16% from $20.1M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of NBP and 11 opened new positions — a net loss of 2 holders — while 15 trimmed existing stakes and 10 added.
The largest buyer was GSA Capital Partners, adding an estimated $512K. The largest seller was Artal Group, exiting entirely with an estimated $1.12M sold.
- 44 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q4 2023, down from 47 in Q3 2023.
- Funds reported $23.5M of NovaBridge Biosciences American Depositary Shares stock for Q4 2023, up 16% quarter-over-quarter.
- 11 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q4 2023 and 13 closed out, a net change of -2 holders.
- The largest NovaBridge Biosciences American Depositary Shares buyer in Q4 2023 was GSA Capital Partners, an estimated $512K added.
- The largest NovaBridge Biosciences American Depositary Shares seller in Q4 2023 was Artal Group, an estimated $1.12M sold.
Based on aggregated 13F filings for Q4 2023.